Advancing the Diagnostic-to-Treatment Continuum in Cancer Care – Arcadia

Located in the greater Los Angeles region, Arcadia, California, provides an ideal setting to bring together experts across oncology, pathology, molecular diagnostics, and translational science, with access to one of the nation’s most dynamic cancer research and clinical communities.

Presented in partnership with City of Hope and chaired by Stephen Gruber, MD, this multidisciplinary conference will explore the discoveries, technologies, and therapeutic advances transforming precision cancer care – from increasingly sophisticated molecular characterization to more individualized treatment strategies.

Through expert-led presentations, case-based education, and collaborative panel discussions, the program will examine emerging developments across solid tumors and hematologic malignancies, with particular attention to the biomarkers and diagnostic insights that are redefining how cancers are classified and treated.

Participants will explore advances in molecular and genomic profiling, biomarker-driven therapy selection, targeted treatments, immunotherapy, liquid biopsy, emerging diagnostic technologies, and evolving standards of care, with an emphasis on translating new science into meaningful clinical decisions.

By bringing oncologists, pathologists, diagnostic specialists, researchers, and other members of the multidisciplinary cancer care team into the same conversation, the Los Angeles conference reflects the way precision oncology is practiced today – connecting discovery, diagnosis, and treatment across the full continuum of cancer care.